Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Use of SERMs for the adjuvant therapy of early-stage breast cancer
Antonio C. Wolff
, Nancy E. Davidson
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
8
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Use of SERMs for the adjuvant therapy of early-stage breast cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemical Compounds
Tamoxifen
95%
Adjuvant
86%
Estrogen
49%
Toremifene
43%
Selective Estrogen Receptor Modulator
37%
Steroid Hormone
29%
Hormone
23%
Agonist
22%
Antagonist
21%
Protein
19%
Drug
12%
Arts & Humanities
Breast Cancer
100%
Therapy
54%
Estrogen
53%
Protein
33%
Food and Drug Administration
33%
Hormones
28%
Chemotherapy
18%
Steroids
16%
Antagonist
16%
In Situ
14%
Suppression
14%
Transcription
13%
Gene
12%
Drugs
11%
Conservation
11%
Medicine & Life Sciences
Selective Estrogen Receptor Modulators
93%
Breast Neoplasms
44%
Tamoxifen
31%
United States Food and Drug Administration
19%
Toremifene
16%
estrophilin
14%
Hormones
14%
Aromatase Inhibitors
12%
Carcinoma, Intraductal, Noninfiltrating
11%
Steroid Receptors
11%
Therapeutics
11%
Adjuvant Chemotherapy
10%
Estrogens
8%
Recurrence
5%
Pharmaceutical Preparations
4%
Genes
4%
Proteins
3%